ahlam1399
09-12-2016, 05:23 AM
BRIEF-BeiGene receives approval to initiate clinical trials in China with PD-1 antibody BGB-A317
* Beigene Receives Approval To Initiate Clinical Trials InChina With Pd-1 antibody bgb-a317http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=u41fCM5K34g:-AQVrGwiHTw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=u41fCM5K34g:-AQVrGwiHTw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/u41fCM5K34g
* Beigene Receives Approval To Initiate Clinical Trials InChina With Pd-1 antibody bgb-a317http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=u41fCM5K34g:-AQVrGwiHTw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=u41fCM5K34g:-AQVrGwiHTw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=u41fCM5K34g:-AQVrGwiHTw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/u41fCM5K34g